Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive AdenocarcinomaMadhusmita Behera, Gabriel Sica, Taofeek K. Owonikoko et al.|Clinical Lung Cancer|2016Cited by 94
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal MalignanciesKevin E. Fisher, Michael R. Rossi, Harold C. Sullivan et al.|Journal of Molecular Diagnostics|2016Cited by 69
Angiotensin-Converting Enzyme N-Terminal Inactivation Alleviates Bleomycin-Induced Lung InjuryPing Li, Sébastien Fuchs, Hong Xiao et al.|American Journal Of Pathology|2010Cited by 49
Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung CancerSuresh S. Ramalingam, Fadlo R. Khuri, Taofeek K. Owonikoko et al.|Journal of Thoracic Oncology|2013Cited by 39
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung CancerTaofeek K. Owonikoko, Fadlo R. Khuri, Suresh S. Ramalingam et al.|Clinical Cancer Research|2015Cited by 26